-
1دورية أكاديمية
المؤلفون: Eiji Kutoh, Alexandra N. Kuto, Rumiko Okada, Midori Akiyama, Rumi Kurihara
المصدر: Medicina, Vol 60, Iss 6, p 991 (2024)
مصطلحات موضوعية: insulin resistance, very low-calorie Japanese diet, pioglitazone, SGLT-2 inhibitor, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: https://www.mdpi.com/1648-9144/60/6/991Test; https://doaj.org/toc/1010-660XTest; https://doaj.org/toc/1648-9144Test
-
2دورية أكاديمية
المؤلفون: Dimitrios Patoulias, Christodoulos Papadopoulos, Ioanna Zografou, Alexandra Katsimardou, Asterios Karagiannis, Michael Doumas
المصدر: Medicina, Vol 58, Iss 9, p 1167 (2022)
مصطلحات موضوعية: SGLT-2 inhibitor, empagliflozin, dapagliflozin, arterial stiffness, pulse wave velocity, cardiovascular disease, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: https://www.mdpi.com/1648-9144/58/9/1167Test; https://doaj.org/toc/1010-660XTest; https://doaj.org/toc/1648-9144Test
-
3دورية أكاديمية
المؤلفون: Sopak Supakul, Yurika Nishikawa, Masanori Teramura, Tetsuro Takase
المصدر: Medicina, Vol 58, Iss 6, p 815 (2022)
مصطلحات موضوعية: sodium-glucose cotransporter-2 (SGLT-2) inhibitor, empagliflozin, dehydration, Medicine (General), R5-920
وصف الملف: electronic resource
العلاقة: https://www.mdpi.com/1648-9144/58/6/815Test; https://doaj.org/toc/1010-660XTest; https://doaj.org/toc/1648-9144Test
-
4
المؤلفون: Maria Elena Liberti, Giuseppe Conte, Carlo Garofalo, Michele Provenzano, Michele Andreucci, Silvio Borrelli, Roberto Minutolo, Luca De Nicola
المساهمون: Garofalo, Carlo, Borrelli, S., Liberti, M. E., Andreucci, M., Conte, G., Minutolo, R., Provenzano, M., De Nicola, L.
المصدر: Medicina, Vol 55, Iss 6, p 268 (2019)
Medicinaمصطلحات موضوعية: medicine.medical_specialty, Population, Review, Infections, survival, albuminuria, GFR, Diabetic Ketoacidosis, End stage renal disease, Nephropathy, Fractures, Bone, Diabetes mellitus, medicine, Humans, Diabetic Nephropathies, Intensive care medicine, education, Sodium-Glucose Transporter 2 Inhibitors, end stage renal disease, Canagliflozin, lcsh:R5-920, education.field_of_study, diabetes, business.industry, SGLT-2 inhibitors, Type 2 Diabetes Mellitus, General Medicine, Acute Kidney Injury, medicine.disease, Neuroprotective Agents, Treatment Outcome, Diabetes Mellitus, Type 2, diabete, Urinary Tract Infections, SGLT-2 inhibitor, Albuminuria, medicine.symptom, lcsh:Medicine (General), business, chronic kidney disease, Kidney disease, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2eabd80a5fa1d38e04ddd534ed3fb47Test
https://doi.org/10.3390/medicina55060268Test